Search results for " BURDEN"

showing 10 items of 325 documents

FROM UNBURDENING TO LIBERATED EMBODIED SIMULATION A HISTORY OF CONCEPTS

2020

What is imagination? How to think this «act» (action)? How to describe its phenomenology? And, above all, how to situate its very space in human behavior and mind? Can we outline a topic of imagination? I suggest that an ap- propriate blend between the tradition of philosophical anthropology, from Johann Gottfried Herder to Hans Blumenberg, and the new neuroscientific interpretation of «embodied simulation», could help us to refine our concept of imagination. I quote Herder just to refer to a noble forerunner of this genealogy, being the focus of my paper on a more controversial figure, namely Arnold Gehlen, author of an inspiring work of twentieth-century anthropology, Man. His Nature and …

Settore L-FIL-LET/14 - Critica Letteraria E Letterature ComparatePhilosophical Anthropology Imagination Impotency Uncertainty Un- burdening. Compensation Hiatus.
researchProduct

ALEXITHYMIA, BURDEN AND EMOTIONAL STATE IN ALS’ CAREGIVERS

2016

Introduction: Living with a progressively disease such as Amyotrophic lateral sclerosis (ALS) has a strong impact on the people affected and on their relatives, who have to tackle the demanding duties of caring for and assisting them (Tramonti et al., 2014). Although an extensive literature documents the levels of distress among caregivers of patients with progressive illness, less attention has been directed to determinants of caregiver mood and emotional regulation (Rabkin et al., 2009). In particular, there are not studies that assess the role of alexithymia in ALS. We evaluated the relationship between alexithymia and burden, and psychopatological symptoms in ALS’caregivers. Methods: 17…

Settore M-PSI/08 - Psicologia ClinicaALEXITHYMIA BURDEN ALS
researchProduct

Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cog…

2013

Abstract Background Drugs with anticholinergic effects are associated with adverse events such as delirium and falls as well as cognitive decline and loss of independence. Objective The aim of the study was to evaluate the association between anticholinergic burden and both cognitive and functional status, according to the hypothesis that the cumulative anticholinergic burden, as measured by the Anticholinergic Cognitive Burden (ACB) Scale and Anticholinergic Risk Scale (ARS), increases the risk of cognitive decline and impairs activities of daily living. Methods This cross-sectional, prospective study (3-month telephone follow-up) was conducted in 66 Italian internal medicine and geriatric…

Settore MED/09 - Medicina InternaHospitalized Elderly: Anticholinergic Risk ScaleAnticholinergic BurdenSettore BIO/14 - FarmacologiaSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheCognitive and Functional StatuAnticholinergic Risk Scale [Anticholinergic Burden; Cognitive and Functional Status; Hospitalized Elderly]
researchProduct

Increased frequencies of CD11b+CD33+CD14+HLA-DRlowmyeloid-derived suppressor cells are an early event in melanoma patients

2014

Myeloid-derived suppressor cells (MDSC) are a heterogeneous cell population characterized by immunosuppressive activity. Elevated levels of MDSC in peripheral blood are found in inflammatory diseases as well as in malignant tumors where they are supposed to be major contributors to mechanisms of tumor-associated tolerance. We investigated the frequency and function of MDSC in peripheral blood of melanoma patients and observed an accumulation of CD11b(+) CD33(+) CD14(+) HLA-DR(low) MDSC in all stages of disease (I-IV), including early stage I patients. Disease progression and enhanced tumor burden did not result in a further increase in frequencies or change in phenotype of MDSC. By investig…

Skin Neoplasmsmedicine.medical_treatmentCD14Sialic Acid Binding Ig-like Lectin 3CD33PopulationLipopolysaccharide ReceptorsReceptors Antigen T-CellDermatologyBiologyLymphocyte ActivationT-Lymphocytes RegulatoryBiochemistryImmune toleranceTetanus ToxoidHLA-DRmedicineHumansMyeloid CellsLymphocyte CounteducationMelanomaMolecular BiologyCells CulturedCell ProliferationNeoplasm Stagingeducation.field_of_studyCD11b AntigenMelanomaInterleukin-8HLA-DR AntigensImmunotherapymedicine.diseaseCoculture TechniquesTumor BurdenCase-Control StudiesImmunologyDisease ProgressionLeukocytes MononuclearMyeloid-derived Suppressor CellTumor EscapeExperimental Dermatology
researchProduct

The defendant’s guilt beyond a reasonable doubt in the Italian criminal justice system

2021

The criminal law standard of Beyond A Reasonable Doubt (BARD) constitutes an evidentiary and judicial rule, formulated and applied for centuries in common law jurisdictions, which was expressly stated in the Italian Code of Criminal Procedure only about fifteen years ago. Unfortunately, the concept of reasonable doubt is inherently complex and does not easily lend itself to definition or refinement. In this regard, the Author examines especially the various positions and elaborations developed by legal literature and case-law in Italy, proposing a specific interpretation of the BARD rule that enhances and completes the particular procedural connotations of the adversarial system adopted i…

Sociology and Political ScienceCommon lawO standard penal do Beyond A Reasonable Doubt (BARD) constitui uma regra de prova e de juízo formulada e aplicada durante séculos em jurisdições de common law que foi expressamente introduzida no Código de Processo Penal italiano apenas cerca de quinze anos atrás. Infelizmente o conceito dedúvida razoável é inerentemente complexo e não se presta facilmente a uma definição ou a uma melhor delimitação. Diante disso o autor examina sobretudo as diferentes posições e elaborações desenvolvidas pela doutrina e pela jurisprudência na Itália oferecendo uma interpretação específica da regra BARD que valoriza e completa as conotações processuais particulares do sistema acusatório adotado na justiça penal italiana.Criminal procedureAdversarial systemreasonable doubtPolitical sciencefair trial.criminal procedureReasonable doubtPresumption of innocenceInterpretation (philosophy)dúvida razoável; processo penal; presunção de inocência; ônus da prova; standard de pro-va; método de raciocínio judicial; justo processo.judicial reasoning methodKPsychiatry and Mental healthreasonable doubt; criminal procedure; presumption of innocence; burden of proof; stand-ard of proof; judicial reasoning method; fair trial.AnthropologyLawSettore IUS/16 - Diritto Processuale PenaleCriminal lawpresumption of innocencestand-ard of proofburden of proofLawSafety ResearchSettore IUS/17 - Diritto PenaleCriminal justice
researchProduct

Recurrence of hepatocellular carcinoma after liver transplantation: an update.

2015

Liver transplantation is the only curative alternative for selected patients with hepatocellular carcinoma (HCC) who are not eligible for resection and/or with decompensated cirrhosis. According to Milan criteria the 5-year survival rate is 70–85%, with a recurrence-free survival of 75%. However, HCC recurrence rate after liver transplantation remains a significant problem in the clinical practice. The prognosis in patients with HCC recurrence is poor. The treatment of choice for HCC recurrence is surgery, but it seems that a systemic treatment based on combination of an mTOR inhibitor with sorafenib can be used. Data on safety and efficacy are limited, clinical monitoring is necessary. Th…

SorafenibOncologyCancer Researchmedicine.medical_specialtyrecurrenceCarcinoma Hepatocellularmedicine.medical_treatmentliving donorLiver transplantationMilan criteriaGastroenterologyLeukocyte CountRisk FactorsInternal medicinemedicineBiomarkers TumorCombined Modality TherapyHumansalpha-FetoproteinPerioperative PeriodSurvival rateimmunosuppressionbusiness.industryRisk FactorLiver NeoplasmsImmunosuppressionGeneral MedicinePerioperativehepatocellular carcinomamedicine.diseaseCombined Modality Therapydigestive system diseasesLiver TransplantationTumor BurdenOncologyLiver NeoplasmHepatocellular carcinomaalpha-FetoproteinsNeoplasm Recurrence Localbusinessmedicine.drugHumanFuture oncology (London, England)
researchProduct

Efficacy but not effectiveness of sublingual immunotherapy for grass pollen allergy: Time to avoid waste in health-care expenditure

2015

Sublingual immunotherapymedicine.medical_specialtybusiness.industryAllergenTreatment outcomeGrass pollenAlternative medicineWelfareRhinitis Allergic SeasonalGrass pollen allergyEconomic burdenAntigens PlantHealth Care CostTreatment OutcomeGrass pollenImmunologyHealth careInternal MedicinemedicineMeta-analysiSublingual immunotherapyIntensive care medicinebusinessDecision-makingHumanEuropean Journal of Internal Medicine
researchProduct

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2020

Abstract: Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. Methods Th…

Systems AnalysisGoutCost effectiveness030204 cardiovascular system & hematologyGlobal HealthGLOMERULAR-FILTRATION-RATEGlobal Burden of DiseaseCOST-EFFECTIVENESS0302 clinical medicineCause of DeathPrevalenceGlobal healthDiabetic NephropathiesRegistries030212 general & internal medicineSUB-SAHARAN AFRICA11 Medical and Health SciencesIncidenceMortality rate1. No povertyGeneral MedicineHälsovetenskaperGBD Chronic Kidney Disease CollaborationCKD-EPI EQUATION3. Good healthEuropeCardiovascular Diseases/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingQuality-Adjusted Life YearsLife Sciences & BiomedicineAsiaOceania195 COUNTRIESATHEROSCLEROSIS RISKCARDIOVASCULAR OUTCOMESRisk AssessmentArticle03 medical and health sciencesMedicine General & InternalSDG 3 - Good Health and Well-beingRISK-FACTORGeneral & Internal MedicineEnvironmental healthHealth SciencesmedicineHumansGBD chronic kidney diseaseMortalityRisk factorRenal Insufficiency ChronicDisease burdenQMScience & TechnologyAustralasiabusiness.industryPERIPHERAL ARTERIAL-DISEASEBayes Theoremmedicine.diseaseHealth SurveysQuality-adjusted life yearRENAL-DISEASELatin AmericaYears of potential life lostAfricaNorth AmericaHuman medicinebusinessRCKidney disease
researchProduct

Tax Performance Assessment in Scandinavian Countries

2015

Abstract The aim of this paper is to evaluate fiscal policy performance level in Nordic countries of Europe by quantifying the gap between their performance and an optimum benchmark value. In this study it was selected Denmark, Finland, Sweden and Norway. These countries occupy the first places in the ranking of countries with the highest rate of tax burden in Europe. The first part of paper contains general aspects of fiscal performance in international research and an overview of the Nordic tax systems model. The second part of paper focuses on evaluation of tax policy performance in these countries by using OptimTax scoring analysis. The research is based on a multivariate analysis instr…

Tax policytax burden rateDouble taxationtax policySocial PsychologyPublic economicsHF5001-6182Economics Econometrics and Finance (miscellaneous)International economicsTax reformDividend taxValue-added taxAd valorem taxTax credittax burden rate tax policy tax performance tax optimumState income taxEconomicsBusiness Management and Accounting (miscellaneous)Businesstax performancetax optimumStudies in Business and Economics
researchProduct

Il ruolo del white paper sulle offerte al pubblico di cripto-attività alla luce della proposta MiCA

2022

La proposta MiCA, nel regolare il white paper sulle offerte di crypto-assets, sembra tenere in considerazione i benefici e i limiti dei sistemi di voluntary e di mandatory disclosure, non optando integralmente né per il primo, né per il secondo. In quest’ottica, se può condividersi l’approccio regolamentare diretto a graduare, a seconda della tipologia di token offerto, sia il contenuto che l’assoggettamento del documento a mera notifica o ad approvazione ex ante da parte dell’Autorità competente, dubbi sorgono in ordine all’indistinta allocazione dell’onere della prova in capo all’oblato, nei casi di violazione della disciplina del relativo white paper.

The MiCa proposal in the regular white paper on crypto-assets offerings seems to take into account the benefits and limitations of voluntary and mandatory disclosure systems not opting for either the former or the latter in full. On one hand one can agree with the regulatory approach aimed at adapting the content of the white paper to the type of token offered and at making the white paper either subject to mere notification or to the approval by the competent Authority depending on the asset offered. On the other hand doubts arise on the indistinct allocation of the burden of proof to the user in case of infringement of the relevant white paper framework.Settore IUS/04 - Diritto Commerciale
researchProduct